SEC Company Response from Traws Pharma, Inc. (TRAW) (CIK 0001130598) (TRAW) — May 15, 2020
Traws Pharma, Inc. (TRAW) (CIK 0001130598)
Date: May 15, 2020 · CIK: 0001130598 · Accession: 0001104659-20-062708
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237844
Letter
Onconova Therapeutics, Inc.
375 Pheasant Run
Newtown, PA 18954
May 15, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Paul Fischer
Celeste M. Murphy
Re: Onconova Therapeutics, Inc.
Registration Statement on Form S-3
Filed April 24, 2020
File No. 333-237844
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconova Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on May 18, 2020, or as soon as practicable thereafter.
ONCONOVA THERAPEUTICS, INC.
By: /s/ MARK GUERIN
Name: Mark Guerin
Title: Chief Financial Officer
Show Raw Text
CORRESP
1
filename1.htm
Onconova Therapeutics, Inc.
375 Pheasant Run
Newtown, PA 18954
May 15, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Paul Fischer
Celeste M. Murphy
Re: Onconova Therapeutics, Inc.
Registration Statement on Form S-3
Filed April 24, 2020
File No. 333-237844
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended,
Onconova Therapeutics, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced
registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time)
on May 18, 2020, or as soon as practicable thereafter.
ONCONOVA
THERAPEUTICS, INC.
By:
/s/ MARK
GUERIN
Name:
Mark Guerin
Title:
Chief Financial Officer